Exelixis (EXEL)
(Delayed Data from NSDQ)
$23.73 USD
-0.13 (-0.54%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $23.70 -0.03 (-0.13%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $0.29 | 0.00% |
Earnings Summary
For their last quarter, Exelixis (EXEL) reported earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.31 per share. This reflects a positive earnings surprise of 6.45%. Look out for EXEL's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of $0.29 per share, reflecting a year-over-year increase of 81.25%.
Earnings History
Price & Consensus
Zacks News for EXEL
The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys
EXEL: What are Zacks experts saying now?
Zacks Private Portfolio Services